These findings are consistent with previous in vivo results showing that modulation of AMPK activity in the hippocampus of both STZ and APP/PS1 mice ameliorates the AD-like pathology and spatial memory dysfunction [31]. The gene discussed is APP; the disease is Alzheimer disease.